Disc Medicine eyes standard US approval for drug after FDA denies fast-track nod

By Siddhi Mahatole Feb 17 (Reuters) - Disc Medicine said on Tuesday it will pursue a traditional U.S. approval pathway for ...

Herc Holdings outlines 13%-17% rental revenue growth target for 2026 amid accelerated integration and specialty expansion

The company is targeting "rental revenue growth of 13% to 17% this year." Humphrey projected "incremental revenue synergies of approximately $100 million to $120 million" and said, "Cost synergies are ...

Chuck Oliver, CEO of The Hidden Wealth Solution, Explains Why Tax Strategy May Matter More Than Market Returns

According to Chuck Oliver, CEO of The Hidden Wealth Solution, tax planning should not be treated as an afterthought to investment management. Instead, it should serve as the structural foundation of a ...

Darwin’s new data centre powering along with 80 per cent local participation

Construction on Darwin’s giant NextDC D2 $132m data centre has hit recent milestones, with the project achieving structural completion on target late last year and hosting a topping out ceremony on ...
Cantech Letter

OS Therapies Provides Global Regulatory Update for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metstatic Osteosarcoma

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...